The searchable archive below contains a list of Knight ADRC Tuesday Seminar presenters, the date of their presentation, institutional affiliation, and the title of their talk. The archive starts in 2000 with listings displayed in reverse chronological order (most recent first). Note that prior to 2020, some events may be missing or inaccurate due to last minute changes/cancellations.

Total Entries: 1317


 

DatePresenterAffiliationTitle
November 11, 2014Michael Ward, MD, PhD

University of California, San Francisco

TBA
November 4, 2014Kiran Yanamandra, PhD

WashU

Effects of Peripheral Administration of an Anti-Tau Antibody in P301S Tau Transgenic Mice
October 28, 2014David Carr, MD

WashU

Exercise, Cognition, and Alzheimer’s Disease: Doing a Dance with the Evidenced-Based Literature
October 21, 2014Deborah Dalin Guyer, MA

American Parkinson Disease Association (APDA) Greater St. Louis Chapte

To Ease the burden – Find the Cure: Where Are We Now? Update on the Greater St. Louis Chapter American Parkinson Disease Association
October 14, 2014Tom Morris, PhD

Macquarie University

Cognitive Discrepancy Analysis in the Detection of Individuals At-Risk for Alzheimer’s Disease
October 7, 2014Goldie Byrd, PhD

North Carolina A&T State University

Engaging Community in the Recruitment of African Americans for Genetic Studies in Alzheimer’s Disease
September 30, 2014Andrew J. Aschenbrenner, MA

WashU

Attentional Control in Semantic Memory Retrieval and AD Biomarkers in Non-Demented Older Adults
September 23, 2014Daniel Blash, PhD

WashU

Diversity & Inclusion 1.0
September 16, 2014Samantha Allison, MA

WashU

TBA
September 9, 2014Jonathan Gooblar, MA, John C. Morris, MD, and Matthew Gabel, PhD

WashU

Disclosure of Individual Research Results to Cognitively Normal Research Participants at the Knight ADRC
September 2, 2014Dayana A. Delgado, MPH

WashU

A Transdiciplinary Approach to Address Alzheimer’s Disease in Missouri
August 26, 2014Marc Diamond, MD

WashU

Implications of Prion Phenomena for Diagnosis and Treatment of Neurodegenerative Diseases
August 19, 2014Kiran Yanamandra, PhD

WashU

Effects of Peripheral Administration of an Anti-Tau Antibody in P301S Tau Transgenic Mice
August 12, 2014Alaina Baker-Nigh, PhD & Chihiro Sato, PhD

WashU

Absolute Quantitation of Apolipoprotein E Isoforms in CSF and Brain of Aged Participants | Elucidating Tau Kinetics with SILK (Stable Isotope Labeling Kinetics) Method
August 5, 2014Alison Goate, D.Phil, Brian Gordon, PhD, and David Clifford, MD

WashU

Annual Alzheimer’s Association International Conference (AAIC) Research Overview
July 29, 2014Aihong Zhou, MD

Xuan Wu Hospital of the Capital Medical University

Regional Variations in PiB Binding In Vivo and the Correlation with the Postmortem Amyloid Assessment in Individuals with Autosomal Dominant Alzheimer
July 22, 2014John Cirrito, PhD

WashU

Serotonin Signaling and Antidepressants Reduce Amyloid-Beta in Mice and Men
July 15, 2014No Seminar

AAIC
July 8, 2014Amy Daitch, PhD

WashU

Flexible Patterns of Neuronal Communication with Attention
July 1, 2014Courtney Sutphen

WashU

TBA
June 24, 2014No Seminar

AAIC Poster Session
June 17, 2014TBA

WashU

Neurology Residents’ Seminar
June 10, 2014John C. Morris, MD

WashU

State of the Knight ADRC
June 3, 2014Celeste Karch, PhD

WashU

Modeling Tauopathies in Human Induced Pluripotent Stem Cells
May 27, 2014Gilbert Gallardo, PhD

WashU

Is Amyotrophic lateral sclerosis Hypertension of the CNS?